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ABSTRACT
Background: Psychological traumatic experiences can lead to posttraumatic stress disorder
(PTSD). Secondary psychotic symptoms are not common but may occur.
Objectives: Since psychotic symptoms of schizophrenia have been related to aberrant
reward processing in the striatum, using the same paradigm we investigate whether the
same finding extends to psychotic and anhedonic symptoms in PTSD.
Methods: A total of 70 male refugees: 18 PTSD patients with no secondary psychotic
symptoms (PTSD-NSP), 21 PTSD patients with secondary psychotic symptoms (PTSD-SP),
and 31 healthy controls (RHC) were interviewed and scanned with functional magnetic
resonance imaging (fMRI) during a monetary incentive delay task. Using region of interest
analysis of the prefrontal cortex and ventral striatum, we investigated reward-related
activity.
Results: Compared to RHC, participants with PTSD had decreased neural activity during
monetary reward. Also, participants with PTSD-SP exhibited decreased activity in the asso-
ciative striatum relative to participants with PTSD-NSP during processing of motivational
reward anticipation which correlated with severity of psychotic symptoms. However, the
difference between the two PTSD groups disappeared when PTSD severity and trauma
exposure were accounted for.
Conclusions: Anhedonia and secondary psychotic symptoms in PTSD are characterized by
dysfunctional reward consumption and anticipation processing, respectively. The latter may
reflect a mechanism by which abnormal reward signals in the basal ganglia facilitates
psychotic symptoms across psychiatric conditions.
Asociaciones de procesamiento neuronal de recompensa con trastorno
de estrés postraumático y síntomas psicóticos secundarios en refu-
giados afectados por trauma
Antecedentes: Las experiencias traumáticas psicológicas pueden conducir al trastorno de
estrés postraumático (TEPT). Los síntomas psicóticos secundarios no son comunes, pero
pueden ocurrir.
Objetivos: Dado que los síntomas psicóticos de la esquizofrenia se han relacionado con el
procesamiento aberrante de recompensas en el cuerpo estriado, utilizando el mismo para-
digma, investigamos si el mismo hallazgo se extiende a los síntomas psicóticos
y anhedónicos en el TEPT.
Método: Un total de 70 refugiados varones: 18 pacientes con TEPT sin síntomas psicóticos
secundarios (TEPT-NSP), 21 pacientes con TEPT con síntomas psicóticos secundarios (TEPT-
SP) y 31 controles sanos (RHC) fueron entrevistados y escaneados con Imagen por resonan-
cia magnética funcional (fMRI en su sigla en inglés) durante una tarea de retraso de
incentivo monetario. Mediante el análisis de la región de interés de la corteza prefrontal
y el estriado ventral, investigamos la actividad relacionada con la recompensa.
Resultados: En comparación con los RHC, los participantes con TEPT habían disminuido la
actividad neuronal durante la recompensa monetaria. Además, los participantes con TEPT-SP
exhibieron disminución de la actividad en el estriado asociativo en relación con los partici-
pantes con TEPT-NSP durante el procesamiento de la anticipación de recompensa motiva-
cional, lo cual estuvo correlacionado con la gravedad de los síntomas psicóticos. Sin
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embargo, la diferencia entre los dos grupos de TEPT desapareció cuando se controlaron la
gravedad del TEPT y la exposición al trauma.
Conclusiones: La anhedonia y los síntomas psicóticos secundarios en el TEPT se caracterizan
por un consumo de recompensa disfuncional y un procesamiento de anticipación, respecti-
vamente. Este último puede reflejar un mecanismo por el cual las señales de recompensa
anormales en los ganglios basales facilitan los síntomas psicóticos a través de afecciones
psiquiátricas.
受创伤的难民中奖赏神经加工与创伤后应激障碍和继发性精神病症状的
关联
背景:心理创伤经历可能导致创伤后应激障碍 (PTSD) 。继发性精神病症状并不常见, 但可
能会发生。
目标:由于精神分裂症的精神病症状与纹状体中奖励加工异常有关, 我们使用相同范式考查
了同样的结果是否可扩展到PTSD中精神病性和快感缺失症状。
方法:共对70名男性难民 (18例无继发性精神病症状的PTSD患者 (PTSD-NSP), 21例有继发性
精神病症状的PTSD患者 (PTSD-SP) 和31名健康对照者 (RHC) 进行了访谈并在一项金钱激励
延迟任务期间进行了功能性磁共振成像 (fMRI) 。我们使用前额叶皮层和腹侧纹状体的感
兴趣区域分析考查了奖赏相关活动。
结果:与RHC相比, PTSD参与者在金钱奖赏期间神经活动减少。此外, 在与精神病症状严重
程度相关的动机奖赏预期处理过程中, PTSD-SP参与者相对于PTSD-NSP参与者表现出相关
纹状体活动减少。但是, 将PTSD严重程度和创伤暴露纳入后两PTSD组之间的差异消失了。
结论:PTSD的快感缺失和继发性精神病症状分别表现为奖赏损耗和预期加工功能失调。后
者可能反映了一种机制:基底神经节中异常奖赏信号促进了跨精神状态的精神病症状。
1. Introduction
Regional crises and wars are continuously occurring, and
2017 set a record with 25.4 million registered refugees in
theworld (TheUNRefugeeAgency, 2017).Most refugees
endure traumatic experiences (e.g. war, torture, famine)
and stressors (e.g. migration, resettlement, poverty), and
15–30% develop posttraumatic stress disorder (PTSD)
and depression (Silove, Ventevogel, & Rees, 2017).
PTSD is a diagnosis characterized by intrusive thoughts,
avoidance, negative mood, and cognitive alterations, as
well as arousal and reactivity in response to
a psychologically traumatic experience (DSM-5) (APA,
2013). Secondary psychotic symptoms (PTSD-SP) may
occur, and suggested criteria include, among others, that
PTSD symptoms precede the onset of psychotic symp-
toms and that the criteria for another psychotic psychia-
tric condition are not met (Compean & Hamner, 2019).
Estimates of PTSD-SP varies across studies, possibly
reflecting variations in the PTSD-SP criteria. While
15–64% of veterans with PTSD from Western countries
have been reported to have PTSD-SP (David, Kutcher,
Jackson, &Mellman, 1999; Kaštelan et al., 2007; Kozarić-
Kovačić & Borovečki, 2005), a prevalence of 41% was
found in a recent study among trauma-affected refugees
with PTSD (Nygaard, Sonne, & Carlsson, 2017). It is still
unclear whether PTSD-SP is related to a complex or
chronic form of PTSD or indicative of severe PTSD
(Compean & Hamner, 2019) and the diagnostic concept
is not recognized in current nosological systems.
Though PTSD is a condition with considerable dis-
turbances in approach behaviour and hedonic deficits,
alterations in the reward system have only scarcely been
investigated (Nawijn et al., 2015). The reward system is
an ensemble of functionally connected brain regions
that enable us to become motivated, approach pleasant
things, and enjoy them. The system has been thor-
oughly investigated in major depression, bipolar disor-
der, and schizophrenia (Whitton, Treadway, &
Pizzagalli, 2015) and has been associated with different
dysfunctions (Caseras, Lawrence, Murphy, Wise, &
Phillips, 2013; Radua et al., 2015). Psychotic symptoms
have been associated with reduced activity in striatal
regions during anticipation of rewards (Caseras et al.,
2013; Radua et al., 2015), while depressive mood relates
to blunted activity during reward consumption in fron-
tal regions (Haber & Knutson, 2010; Knutson, Fong,
Bennett, Adams, & Hommer, 2003). Task-related func-
tional magnetic resonance imaging (fMRI) has been
used in patients with PTSD, showing decreased activity
in the ventral striatum (VS), secondary visual cortices,
and prefrontal cortex during passive viewing of pictures
with positive emotional valence (Felmingham et al.,
2014; Jatzko, Schmitt, Demirakca, Weimer, & Braus,
2006). Decreased activity in the prefrontal cortex and
VS was observed in patients with PTSD in response to
conditioned positive feedback (Sailer et al., 2008).
Decreased activity in the left dorsomedial prefrontal
cortex along with increased activity in the insula was
present when PTSD patients imagined positive social
and non-social events (Frewen et al., 2011). Although
monetary rewards have high incentive value, only
a single fMRI study has used monetary rewards to
probe the reward system in PTSD (Nawijn et al.,
2015). In that study, PTSD patients showed reduced
striatal activation in response to monetary reward and
the reduced responsiveness of ventral striatum to
reward scaled positively with symptoms of anhedonia
(Elman et al., 2009).
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In the present study, we used fMRI during
a monetary incentive delay (MID) paradigm to test
three hypotheses. The first is that PTSD in refugees is
associated with an attenuated neural response in the
frontal cortex when receiving a reward. The second is
that this attenuation correlates with the severity of
anhedonia. Thirdly, we hypothesized that relative to
participants with no secondary psychotic symptoms,
participants with PTSD and secondary psychotic
symptoms would have a reduced neural response in
striatal regions during reward anticipation.
Hypotheses and planned analyses were preregistered
(Uldall, 2016).
2. Methods and materials
2.1. Sample size
The sample size was guided by the hypothesis con-
cerning differences in striatal activation between
PTSD and PTSD-SP participants. We performed
a power calculation with alpha set to .05 and beta to
.8. The standardized difference (1.23) was obtained
from a previous study using approximately the same
reward paradigm as described below (Nielsen et al.,
2012). Sixteen participants in each group were
required to reject the null-hypothesis that activation
of the ventral striatum was not significantly different
in each group during the anticipation phase (see
below).
2.2. Participants
All participants were refugees or family members
reunified with a refugee, and due to another compo-
nent of the project concerning volumetric MR ima-
ging, they were all male. Seventy-eight participants
were included from May 2016 to April 2018.
Participants with PTSD were divided into two
groups: participants with PTSD but no secondary
psychotic symptoms (PTSD-NSP) and participants
with PTSD and secondary psychotic symptoms
(PTSD-SP). Refugees with no psychiatric diagnosis
served as healthy controls (RHC). Participants with
PTSD were recruited at the Competence Centre for
Transcultural Psychiatry (CTP) where multidisciplin-
ary services are provided to trauma-affected refugees
without a primary psychotic or bipolar disorder. Both
patients with ongoing and with previous treatment
for PTSD at CTP were invited to participate. The
RHC group was recruited via advertisements (public
posters and on the Internet) and from family and
acquaintances of interpreters at CTP.
One PTSD and two RHC participants withdrew
consent due to a change of mind, one participant was
later diagnosed with a primary psychotic disorder,
two PTSD and one RHC participants opted out due
to anxiety during the scan, and one RHC participant
could not be scanned due to obesity. Hence, the final
sample consisted of 31 RHC and 39 PTSD patients
(PTSD-all), of whom 18 participants were categorized
as PTSD-NSP participants and 21 as PTSD-SP parti-
cipants. The two PTSD groups were matched for age.
We also strove to match the PTSD-all and RHC
groups for age, but due to limited recruitment possi-
bilities this was not fully attained. The RHC and
PTSD-all groups were not matched for lifetime
trauma experience.
2.3. Inclusion and exclusion criteria
Symptoms of depression before the onset of PTSD
and current or previous manic episodes or primary
psychotic disorders were exclusion criteria. Further,
any individual who had taken antipsychotic medicine
within the last month was excluded, though antide-
pressants were allowed. For all participants, previous
moderate or severe traumatic brain injury (TBI) were
exclusion criteria, though mild TBI was permissible.
To identify TBI, we used the Ohio State University
Identification Method (Corrigan & Bogner, 2007).
Alcohol units < 21/week were accepted, but substance
abuse was not, and all participants underwent
a substance abuse urine test (Rapid Response,
BTNX Inc., Canada) and the Alcohol, Smoking, and
Substance Involvement Screening (ASSIST) (Ali et al.,
2002). MRI exclusion criteria included claustrophobia
and standard MRI safety incompatibility.
2.4. Clinical assessments
To diagnose PTSD, depression, and enduring person-
ality change after a catastrophic experience, all parti-
cipants were interviewed using the Schedules for
Clinical Assessment in Neuropsychiatry (SCAN)
(WHO, 1999). SCAN was also used to exclude parti-
cipants with manic episodes or a primary psychotic
disorder. Participants with PTSD were further inter-
viewed using the Clinician-Administered PTSD Scale
for DSM-5 (CAPS-5), assessed for the past month
(Page et al., 2015). Participants were questioned
about their trauma, medical, social, and smoking
history. All participants filled in the Harvard
Trauma Questionnaire (HTQ), Life Event Checklist
(LEC), and Hopkins Symptoms Check List-25
(HSCL-25). From the HSCL-25, only the depression
items (item 11–25) were used. HTQ and HSCL-25 are
valid questionnaires to assess symptoms of PTSD,
depression, and anxiety in trauma-affected refugees
(Wind, van der Aa, de la Rie, & Knipscheer, 2017).
All questionnaires were available in the participants’
native language, and translators were accessible
throughout the study.
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2.5. Participants with PTSD-SP
To identify PTSD-SP participants, we adhered to the
research criteria for PTSD-SP proposed by Compean
& Hamner (2019). These include a score of minimum
moderate (>3) on at least one positive item on the
Positive and Negative Syndrome Scale (PANSS) (Kay,
Flszbeln, & Qpjer, 1987). The criteria also include
that the participant has preserved reality testing,
that the psychotic symptoms are not limited to flash-
backs, that PTSD symptoms precede the psychotic
symptoms, and that the participants do not meet
the criteria for another psychiatric diagnosis with
psychotic features (Compean & Hamner, 2019). All
participants with psychotic symptoms were evaluated
by a second psychiatrist to assure the exclusion of
participants with primary psychotic disorders.
The second evaluation led to the exclusion of one
participant. An excerpt from the clinical description
of a PTSD-SP participant can be seen in the
Supplementary.
The study was approved by the Danish Ethical
Committee of Science (H-15006293) and the Danish
data protection agency (2012-58-0004). All partici-
pants gave written informed consent. Participants
were compensated with a fee in addition to earnings
from the task described below as well as reimburse-
ments for public transportation.
2.5.1. Experimental design
A modified variant of the monetary incentive delay
(MID) task, as described by Knutson, was used to study
the reward system (see Figure 1) (Knutson, Fong,
Adams, Varner, & Hommer, 2001). The purpose of the
game is to evoke brain activity in relation to the
anticipation of behaviourally important (salient) events
and evaluation of positive and negative outcome. Inside
an MR-scanner, 72 trials were presented, each lasting
8.5 seconds with a total task time of approximately
11 minutes. Each trial was initiated by a 2-second cue
indicating the trial type: Uncertain Gain (up arrow),
Uncertain Lose (down arrow), and Neutral (up and
down arrow). There were 24 trials of each type. This
was followed by a white cross for 2 seconds. Next, a target
appeared for approximately 300 milliseconds, at which
point the participants had been instructed to press
a button. Target duration was adjusted using a staircase
model to secure a hit rate of approximately 66%. Lastly,
feedback was given for 4 seconds. Outcome was either ‘+
50 Danish krone’ (= 7 euro) (successful hit during
Uncertain Gain trial), ‘-50 Danish krone’ (failed hit dur-
ing Uncertain Lose trial), or ‘0’ (successful hit during
‘Uncertain Lose’ trial, failed hit during Uncertain Gain
trial, or any response after Neutral trials). Below the
outcome, total earned money was displayed. Each parti-
cipant had been carefully instructed in the meaning of
each cue and had practiced for 2 × 5minutes beforehand.
The participants were not informed of the adaptive hit
rate. The experiment was performed using Presentation®
software (Version 18.0, Neurobehavioral Systems, Inc.,
Berkeley, CA, www.neurobs.com).
2.5.2. Data acquisition, data pre-processing
stream and radiological assessment
We recorded blood oxygen level dependent (BOLD)
responses during a reward task using a 3T MRI
scanner (3T Phillips Achieva, Phillips Healthcare,
Best, the Netherlands) with a 32-channel head coil
at the Danish Research Centre for Magnetic
Resonance, Hvidovre Hospital. FMRI data processing
Figure 1. Trial task during fMRI.
Seventy participants were subjected to a monetary incentive delay task while undergoing an fMRI session. The task included 72 trials. There
were 3 different trial types (Uncertain Lose, Uncertain Gain, and Neutral). The Uncertain Lose and Uncertain Win trials had a positive and
a negative outcome while the Neutral trial had only a neutral outcome.
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was carried out using FEAT (FMRI Expert Analysis
Tool) Version 6.00, part of FSL (FMRIB’s Software
Library, www.fmrib.ox.ac.uk/fsl). Details on MR
sequences and data pre-processing are provided in
the Supplementary. All clinical scans were evaluated
for structural abnormalities by two senior radiologists
(Madsen, CG and Leffers, A), and participants were
informed of the results of the evaluation. Sixteen
participants (7 HC, 3 PTSD-SP, and 6 PTSD-NSP)
had minor pathological findings such as unspecific
gliosis, partial empty sella turcica, and small ischae-
mic changes, and in five cases this led to further
examinations. No participants were excluded based
on the radiological evaluation as the locations were
not deemed relevant to our brain networks of
interest.
2.5.3. Time series model for individual subjects’
(first-level) analysis
The single-subject general linear model included
a total of nine original explanatory variables (EV)
modelled as stick functions convolved with
a canonical haemodynamic response function. Each
event was determined by onset, duration, and input
value. Each trial type was used as an EV to model the
anticipation to act phase, the action phase (button
press) was modelled as an EV of no interest, and
finally, the five different outcome scenarios were
modelled as separate EVs (see Figure 1). The haemo-
dynamic response function was a double-gamma
function, and temporal derivatives were added to
the model. Twenty-four motion parameters (standard
realignment plus their temporal derivatives and
squares) and individual motion outliers were added
to each model. Individual t-contrasts were used to
generate three contrast images which were analysed
for group differences. For the anticipation to act
phase of the experiment, we formed the Salience
contrast (Uncertain Gain and Uncertain Lose vs.
Neutral), and for the outcome phase we formed the
win contrast (successful hit during an Uncertain Win
trial vs. Neutral) and the negative prediction error
contrast (failed hits during Uncertain Lose and Win
trials vs. Neutral).
2.5.4. Region of interest (ROI)
For group comparisons, we defined an ROI for the
win contrast and the Salience contrast. The evalua-
tion of the hedonic value of stimuli is known to be
processed in the medial orbitofrontal cortex (mOFC)
and medial prefrontal cortex (mPFC), and these areas
have previously been implicated in emotional proces-
sing in PTSD (Frewen et al., 2011; Knutson et al.,
2003; Sailer et al., 2008). We defined the ROI as
voxels activated by the win contrast within the frontal
medial cortex region as defined by Harvard-Oxford
Cortical Structural Atlas (p > 0.05) when analysed
with a one-sample t-test (all participants).
The second ROI was within the striatum and
included both the limbic and associative striatum
since both these regions have been implemented in
psychosis (Kegeles et al., 2010; Kesby, Eyles, McGrath,
& Scott, 2018). We adhered to previous anatomical
definitions of the associative and limbic striatum pro-
vided by Martinez et al. (2003) and created a striatal
mask that covered the nucleus accumbens, precommis-
sural dorsal putamen, precommissural dorsal caudate,
and postcommissural caudate. We used the mask to
restrict the voxel-wise analysis andmultiple comparison
correction.
2.5.5. Statistics
To test the hypothesis that PTSD is associated with an
attenuated neural response in the frontal cortex during
reward consumption, we extracted the mean para-
meter estimate (PE) across the functional ROI of
mPFC (as defined above) for each participant. We
then fitted a model to the data with PE as the depen-
dent variable and Group (RHC/PTSD-NSP/PTSD-SP)
as the independent variable. Age, smoking (yes/no),
and previous mild traumatic brain (mTBI) injury (yes/
no) is known to affect the BOLD signal (Friedman
et al., 2008; McDonald, Saykin, & McAllister, 2012;
Tsvetanov et al., 2015) and were added as covariates,
together with each participant’s total winnings. We
analysed the model with an ANCOVA and used the
covariate-adjusted means to compare RHC with
PTSD-all using a t-test.
The hypothesis concerning an association between
symptoms of anhedonia and neural activity in the
functional ROI of mPFC during reward consumption
among PTSD participants was tested with a linear
regression analysis where the effect of age, smoking
(yes/no), previous mTBI (yes/no), LEC score, HTQ
score, and total winnings had been regressed out. As
a measure of anhedonia, we used the sum of scores
from the three questions in the CAPS-5 that pertain
to symptoms of anhedonia (questions D5, D6, and
D7). To assert if any association between anhedonia
and neural activation could be attributed to symp-
toms of depression, we also ran the regression analy-
sis while further controlling for variations in the
HSCL-25 (depression items) score.
The hypothesis that PTSD-SP is associated with
reduced neural response in striatal regions during
reward anticipation was tested by analysing the
Salience contrast within the striatal mask with
a voxel-wise t-test (PTSD-NSP>PTSD-SP) while con-
trolling for age, smoking (yes/no), previous mTBI
(yes/no), and total winnings. The mean PE from the
activated clusters was tested for associations with the
PANSS-positive subscore using a linear regression
analysis where the effect of age, mTBI, smoking,
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and winning had been regressed out. To examine the
impact of PTSD severity and number of different
traumatic experiences on the Salience contrast we
also ran the voxel-wise t-test (PTSD-NSP>PTSD-SP)
and linear regression analysis with HTQ and LEC-
score as additional covariates/regressors.
For exploratory purposes, we did three whole-brain
ANCOVA voxel-wise analyses of the win, salience and
negative prediction error contrasts with Group (RHC,
PTSD-NSP, PTSD-SP) as between factor.
All voxel-wise analyses were analysed with FSL using
a random effect model. We used threshold-free cluster
enhancement (TFCE) to correct for multiple compar-
ison (Smith & Nichols, 2009). The permutation based
null-distribution was built up from 5,000 random per-
mutations and the 95th percentile, used as a TFCE-
threshold for all analysis, and the significance level
calculated from this distribution. Thus, the maps were
fully corrected for familywise error at p < 0.05. The
winnings were analysed with a one-way ANOVA and
hit rate and response time with a two-way repeated
measures ANOVA. Extracted PE, behavioural, psycho-
pathological, and demographic data were analysed with
MATLAB and Statistics Toolbox Release 2018a, The
MathWorks, Inc., Natick, Massachusetts, USA.
3. Results
3.1. Participants
Two PTSD-SP participants either slept or ignored the
fMRI task and ended with minus 90 and 100 euro.
These two participants were excluded from further
analysis. Participants were primarily from Syria (29%),
Iraq (24%), Afghanistan (20%), and Iran (9%). Yemen,
Bosnia, Lebanon, South Sudan, Egypt, Turkey, and
Jordan were also represented. Table 1 presents the dis-
tribution of sociodemographic variables and traumatic
events, and Table 2 presents the distribution of comor-
bidity, medicine, and psychopathology in PTSD-NSP
and PTSD-SP patients. All participants endorsed at least
one event on the Life Event Checklist. Compared to
RHC, PTSD-all participants were older, smoked more,
had fewer years of education, and had experienced
more traumatic events. Generally, PTSD-SP patients
scored higher on measures of PTSD symptomatology,
and more had endured a mTBI than PTSD-NSP
patients.
3.2. Behavioural results
Figure 2 illustrates the behavioural results. The overall
average winning was 82 euros. A one-way ANOVA
revealed that there were significant differences among
the means of the three groups (F(2,65) = 6.13, p = 0.004).
The ANOVAwith the within-subject factor trial type (3
levels: Uncertain Win, Uncertain Lose and Neutral
trials) and between-subject factor group (RHC, PTSD-
NSP and PTSD-SP) analysis of hit-rate showed a main
effect of trial type (F(2,130) = 3.63, p = 0.029), a main
effect of group (F(2,65) = 3.83, p = 0.02) but no interac-
tion. The 3 × 3 ANOVA of response time showed
a main effect of trial type (F(2,130) = 13.64, p < 0.001),
but no effect of group and no interaction.
4. Brain imaging results
4.1. Reward outcome
4.1.1. Voxel-wise analysis
A voxel-wise one-sample (all participants) t-test analy-
sis of the win contrast revealed significant activation
(p < 0.01) in large regions of the brain, including the
prefrontal cortex, ventral striatum, thalamus, amygdala,
hippocampus, and occipital areas (Figure 3).
4.1.2. Regional analysis
Group difference in PE across the mPFC functional
ROI was first analysed with an ANCOVA with age,
smoking status, brain-injury, and winnings serving as
covariates. There was a main effect of Group (RHC/
PTSD-NSP/PTSD-SP) (F(2,61) = 4.11, p = 0.021) and
Table 1. Sociodemographic and traumatic events.
Statistical test & p-value
Characteristics
PTSD-NSP
(n = 18)
PTSD-SP
(n = 19)
HC
(n = 31) PTSD-all vs. HC PTSD-NSP vs PTSD-SP
Age, mean years (SD) 43 (13) 47 (9) 38 (12) t66 = 2.58, p = 0.012 t35 = 1.03, p = 0.310
Years in Denmark (SD) 13 (11) 16 (11) 15 (10) t66 = 0.08, p = 0.934 t35 = 0.69, p = 0.494
Smokers, No (%) 11 (61) 10 (53) 9 (29) χ2(1) = 5.26, p = 0.022 χ2(1) = 0.27, p = 0.603
Years of education, mean (SD) 13 (5) 13 (5) 15 (3) t66 = 2.46, p = 0.017 t35 = 0.50, p = 0.62
Mild Traumatic Brain Injury, a No (%) 12 (67) 18 (95) 23 (74) χ2(1) = 0.46, p = 0.49 χ2(1) = 4.75, p = 0.029
Age at first traumatic event, mean years
(SD)
18 (7) 20 (11) 17 (8) t66 = 1.25, p = 0.214 t35 = 0.68, p = 0.5
Number of traumatic events,b median
(IQR)
6 (4) 7 (3) 3 (3) t66 = 4.89, p < 0.001 t35 = 0.69, p = 0.493
Torture, No (%) 7 (39) 10 (53) 1 (3) χ2(1) = 15.8, p < 0.001 χ2(1) = 0.7, p = 0.4
Hopkins Symptom Checklist-25,
depression, mean (SD)
2.5 (0.6) 3 (0.4) 1.4 (0.4) t67 = 11.91, p < 0.001 t35 = 3.1, p = 0.004
Harvard Trauma Questionnaire, mean (SD) 2.8 (0.5) 3.1 (0.4) 1.4 (0.4) t66 = 14.8, p < 0.001 t35 = 2.7, p = 0.01
aIncludes report of brain or neck trauma immediately followed by being dazed, having memory lapse, or loss of consciousness for less than 30 minutes.
bNumber of traumatic events that ‘happened to me’ or were witnessed, as defined by the Life Event Checklist-5.
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smoking (yes/no) (F(1,61) = 7.7, p = 0.007) but no effect
of age (p = 0.487), mTBI (p = 0.096) or winnings
(p = 0.138) (Figure 3). The covariate-adjusted means
were used to compare differences between RHC and
PTSD-all and revealed a significant difference of 0.11
signal change (CI: 0.03–0.19, t(1,61) = 2.804, p = 0.007).
4.1.3. Association between anhedonia and neural
activation
For PTSD-all participants, the anhedonia score was
negatively associated with the mean PE (F(1,30) = 7.34,
p = 0.011) after the effect of age, smoking status, brain-
injury, LEC score, HTQ score and winnings had been
regressed out. The association became even stronger
when the regression model also included HSCL-25,
depression subscale (F(1,30) = 10.12, p = 0.003)
(Figure 3).
4.2. Salience contrast
4.2.1. Voxel-wise analysis
The voxel-wise t-test (PTSD-NSP > PTSD-SP) of the
Salience contrast within the striatum mask revealed
that PTSD-NSP had significantly more neural activity
than PTSD-SP in the left precommissural dorsal
putamen (pre-DPU) after controlling for age, brain
Table 2. Comorbidity, psychotropic medicine, and psychopathology among PTSD patients.
Characteristics PTSD-NSP (n = 18) PTSD-SP (n = 19) Statistical test & p-value
Duration of PTSD symptoms, mean years (SD) 14 (10) 13 (9) t35 = 0.36, p = 0.718
Psychiatric co-morbidity, No (%) 15 (83) 17 (90) χ2(1) = 0.29, p = 0.58
Mild depression 7 (39) 0
Moderate depression 6 (33) 10 (53)
Severe depression 1 (6) 7 (37)
Periodic depression 2 (11) 1 (5)
Enduring personality change after catastrophic experience 2 (11) 11 (58)
Psychotropic medicine, No (%) 10 (56) 15 (79) χ2(1) = 2.3, p = 0.13
SSRI, No (%) 4 (22) 7 (37)
Mean mg dose (SD) 113 (25) 115 (50)
SNRI, No (%) 1 (6) 2 (10)
Mean mg dose (SD) 75 (50) 132 (53)
TeCA, No (%) 8 (44) 10 (47)
Mean mg dose (SD) 11 (4) 16 (16)
TCA, No (%) - 2 (10)
Mean mg dose (SD) - 30 (28)
Clinician Administrated PTSD scale for DSM-5
Intrusion symptoms, mean (SD) 12.7 (4.5) 15.9 (3) t35 = 2.6, p = 0.013
Avoidance symptoms, mean (SD) 5.6 (2) 6.4 (1.7) t35 = 1.23, p = 0.22
Cognition and mood symptoms, mean (SD) 12.7 (3.9) 14.2 (2.9) t35 = 1.55, p = 0.129
Arousal and reactivity symptoms, mean (SD) 14.2 (5.9) 17.9 (3.8) t35 = 2.3, p = 0.027
Positive and Negative Symptoms Scale
Positive scale, Mean (SD) 8.9 (1.4) 14.2 (3.2) t35 = 6.32, p < 0.001
Negative scale, Mean (SD) 11.4 (2) 12.9 (4) t35 = 1.4, p = 0.167
General scale, Mean (SD) 25.5 (3.6) 28 (3.9) t35 = 2.19, p = 0.035
Psychotic symptoms
Hallucinatory behaviour≥ 4 No (%) - 12 (63)
Suspiciousness/persecution≥4 No (%) - 13 (69)
SSRI = Selective serotonin reuptake inhibitor
SNRI = Serotonin-norepinephrine reuptake inhibitor
TeCA = Tetracyclic antidepressant
TCA = Tricyclic antidepressant
Figure 2. Behavioural measures.
Left panel: PTSD-SP participants won significantly less than PTSD-NSP participants (p = 0.024) and RHC (p = 0.002). Middle Panel: Across
participants hit rate was higher for Uncertain Win and Lose trial than Neutral trials (p = 0.006 and p = 0.044, respectively). RHC had a higher hit
rate than PTSD-SP participants during Uncertain Lose trials (p = 0.006). Right panel: Overall, the response time was higher for Uncertain Lose
trials compared to Uncertain Win trials (p = 0.003). Errorbars indicate standard error.
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injury, smoking, and winning (voxels: 14, max
t-score: 3.8, MNI: −26 8 0) (Figure 4). The mean PE
from the activated voxels in pre-DPU was negatively
associated with the PANSS-positive subscores, after
having controlled for the effect of age, mTBI, smok-
ing, and winning (F(1,28) = 4.16, p = 0.049) (Figure 4).
This association disappeared when either the HTQ
score or LEC score was additionally controlled for
(p = 0.167 and p = 0.083, respectively). When the
HTQ score or LEC score was added as covariates to
the voxel-wise t-test (PTSD-NSP > PTSD-SP) no
voxels survived the statistical threshold.
Of the covariates, age was negatively correlated to the
Salience contrast in the right pre-DPU (voxels:19, max
t-score: 3.8, MNI: 24 4 8), total amount won was posi-
tively correlated in the left pre-DPU (voxels: 10, max
t-score: 3.96, MNI: −22 8 − 6), and mild traumatic brain
injury was positively correlated in the right caudate
(voxels: 5, max t-score: 3.96, MNI: 10 10 14).
4.3. Exploratory tests
There were no significant clusters in the exploratory
whole-brain one-way ANOVA voxel-wise analyses of
the win, salience, and negative prediction error
contrasts.
5. Discussion
This is, to the best of our knowledge, the first study to
compare two PTSD groups, with and without second-
ary psychotic symptoms, and a healthy control group
using monetary incentives to probe the reward system
during fMRI. The results confirmed our hypotheses
Figure 3. Win contrast.
Brain images: t-score map for average activation across participants in the win contrast, thresholded at p < 0.01 and overlayed an average of
participants’ T1-weighted image. The turquoise area represents the mPFC ROI from which participants’ mean PE were extracted. Middle panel:
The ANCOVA revealed a main effect of Group (RHC/PTSD-NSP/PTSD-SP) on mean PE derived from the functional mPFC ROI. Adjusted for age,
brain injury, smoking, and winning. The errorbar indicates the standard error of the mean (SEM). Right panel: The anhedonia score in PTSD-all
participants was significantly associated with the signal change in PTSD-all participants. Adjusted for age, brain injury, smoking, winning, LEC
score, HTQ score, and HSCL-25 (depression items).
Figure 4. Salience contrast.
Brain images: The turquoise area represents the salience ROI. In 14 voxels (max t-score: 3.7, MNI: −26 8 0) PTSD-NSP participants had more
activity than PTSD-SP patients analysed voxel-wise, and after correction for multiple comparison (p < 0.05), and controlling for age, brain injury,
smoking, and winning. Middle panel: The mean PE from the salience, anticipation to win and anticipation to lose contrast maps across the 14
voxels. The plot shows that the difference in the Salience contrast was driven by both the Anticipation to Lose and Win signal. Right panel:
The PANSS-positive score was significantly associated to the mean PE extracted from the activated cluster. Adjusted for age, brain injury,
smoking, and winnings. The errorbar indicates the standard error of the mean (SEM).
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that monetary reward consumption evokes a weaker
medial prefrontal reward response in PTSDparticipants
than in healthy controls, and that deficient reward out-
come processing in mPFC scales with the severity of
anhedonia. Further, PTSD patients with secondary psy-
chotic symptoms showed a reduced signal in a part of
the associative striatum during salience processing. The
reduced activation in response to reward anticipation
showed a significant negative linear relationship with
the individual PANSS-positive sub-scores. The lower
the anticipatory reward signal, the higher was the
PANSS-positive score. When the analysis accounted
for differences in number of traumatic experiences or
PTSD-severity, the differences during Salience proces-
sing between PTSD-SP and PTSD-NSP participants
disappeared.
Results from previous studies examining the neu-
robiology of anhedonia in PTSD have been conflict-
ing (Nawijn et al., 2015), but in accordance with our
study PTSD patients have been found to have rela-
tively blunted activity in mPFC when exposed to
conditioned positive feedback (Sailer et al., 2008)
and imagery of positive social events (Frewen et al.,
2011). Moreover, our results are in line with general
findings where the neural processing for reward con-
sumption has been shown to mainly include mPFC
(Haber & Knutson, 2010; Knutson et al., 2003). The
findings further imply that in this region, anhedonia
conveys changes in the subjective value of money for
male refugees with PTSD.
A neural basis for anhedonia in mPFC is not
unique to PTSD and has been found in schizophrenia
(Lee, Jung, Park, & Kim, 2015) and major depression
(Keedwell, Andrew, Williams, Brammer, & Phillips,
2005). However, this is not surprising, as similar
psychopathology across psychiatric conditions is
likely to share neuropathogenic mechanisms (Insel
et al., 2010). In this vein, it is interesting to consider
systemic inflammation as a mediating link between
anhedonia and diminished prefrontal activity across
psychiatric conditions (Bauer & Teixeira, 2019; Freed
et al., 2018; Stanton, Holmes, Chang, & Joormann,
2019). In this regard, anti–inflammatory treatment
might be promising in treating anhedonia in some
PTSD patients, as preliminary studies have shown it
to be efficient in treating subgroups of patients with
depression and schizophrenia (Khandaker et al.,
2015; Miller & Raison, 2016). Further, treatments
such as repetitive transcranial magnetic stimulation
(Pettorruso et al., 2018) and nasal administration of
oxytocin (Koch et al., 2016) appear promising for
treating anhedonia and low mPFC activity, and
might also prove valuable future options in the treat-
ment of anhedonia in PTSD.
The associative striatum is involved when the moti-
vational value of a stimulus is processed (Kesby et al.,
2018; Winton-Brown & Fusar-Poli, 2014). When the
salient and insignificant cues were processed with the
same neural effort in PTSD-SP, it could have been
indicative of the cues being attributed the same level
of motivational value. According to the aberrant sal-
ience hypothesis of psychosis (Kapur, 2003), psychotic
symptoms arise because internal and external mental
representations are (aberrantly) attributed the same
degree of meaning (salience). On a biological level,
this can occur when an elevated tonic dopaminergic
activity in the striatum prohibits any stimulus from
effectively differentiating itself. An alternative interpre-
tation of the associative striatum’s role in psychosis is
linked to its involvement in habit formation and the
coding of stable values (McCutcheon, Abi-Dargham, &
Howes, 2019). In this vein, excessive dopaminergic
activity is suggested to cause psychotic symptoms
because it leaves the patient in a conservative mode of
cognition with rigid forms of thought (McCutcheon
et al., 2019).
In schizophrenia, psychotic symptoms have been
linked to increased synaptic dopamine function in the
associative striatum (Kegeles et al., 2010), and one
might speculate whether dysfunctional dopaminergic
activity is responsible for secondary psychotic symp-
toms in PTSD. While PTSD is primarily considered
a disorder of serotonin, noradrenalin, and glutamate
(Kelmendi et al., 2016), it is also known that stress
can increase dopaminergic activity in the central ner-
vous system (Kaneyuki et al., 1991; Lindley,
Bengoechea, Schatzberg, & Wong, 1999; Posener
et al., 1999). As in our study, PTSD-SP has been
linked to increased stress, as suggested by more
severe PTSD symptoms (Kaštelan et al., 2007; Pivac
et al., 2007, 2006). Moreover, PTSD-SP has been
associated with increased activity of monoamine oxi-
dase inhibitor B, which, among other functions, cat-
alyses the oxidation of dopamine (Pivac et al., 2007).
Hence it is possible that PTSD-SP constitutes
a subgroup of PTSD in which a high level of stress
leads to high symptom load, increased dopamine
activity, and secondary psychotic symptoms. Future
studies on PTSD-SP could investigate this with, for
instance, positron emission tomography (PET),
where the level of dopamine can be measured
directly. The finding that the differences between
the PTSD-SP and PTSD-NSP groups disappeared
when taking the HTQ and LEC scores into account
further suggests that PTSD-SP and the associated
changes in reward processing are better explained
by the number of traumas and/or PTSD severity.
6. Limitations
Although the estimation of the sample size of this study
was guided by a power calculation, the sizes of the two
PTSD groups were small in comparison to current inter-
national standards. Consequently, there is a risk of false
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negative results. This might explain the lack of significant
results from the whole-brain voxel-wise analysis.
Since trauma exposure has been associated with
reward processing deficits irrespective of a PTSD diag-
nosis (Stanton et al., 2019), use of trauma-affected
healthy controls (though less affected than the PTSD
participants) in this study may conceal any potential
effects of the traumatic events per se. Therefore, the
results are likely to primarily concern changes in neural
activation either related to having experienced multiple
traumas and/or the transition from being trauma-
affected to developing PTSD. Antidepressants have
been shown to augment striatal neural activity
(Ossewaarde et al., 2011), and the use of antidepressants
in our PTSD participants therefore limits the general-
izability of our results to medication-free PTSD popula-
tions. As many patients develop depression prior to
PTSD, our exclusion of participants with depressive
symptoms before the onset of PTSD limits the general-
izability of the results. Also, as most of the PTSD parti-
cipants had depression, it is important to emphasize
that our results do not extend to PTSD populations
without co-morbid depression. However, since both
depression and enduring personality change after
a catastrophic experience typically develop after sus-
tained PTSD symptoms, and their presence are best
thought of as indicators of severe PTSD (O’Donnell,
Creamer, & Pattison, 2004), our results can be general-
ized to a clinically relevant PTSD population. Finally,
longitudinal studies are needed to assert whether, for
instance, biological dispositions to reward system defi-
cits contribute to the development of anhedonia and
secondary psychotic symptoms in PTSD.
We used interpreters, which increases the risk of mis-
communication, though it is not our impression that any
clinically valuable information was lost in translation.
Our three groups differed in age, smoking status, pre-
valence of mild head-injury, and task-related winning,
and these variables were added as covariates of no inter-
est in all comparisons whereby the risk of confounding
was limited (Friedman et al., 2008;McDonald et al., 2012;
Tsvetanov et al., 2015). Finally, our PTSD sample con-
sisted of treatment-seeking male refugees with chronic
PTSD and a high trauma load. Albeit that various
trauma-affected populations share the PTSD diagnosis,
it is becoming increasingly clear that PTSD is
a heterogenous disorder (Galatzer-Levy & Bryant, 2013)
with corresponding variations in the biological under-
pinning (Marinova &Maercker, 2015). Thus, our results
should be interpreted with caution in PTSD samples
other than trauma-affected male refugees.
7. Conclusion
We found a decreased activity in mPFC during
monetary reward consumption in all PTSD patients,
which correlated with anhedonia severity. Decreased
activity in the left associative striatum during antici-
pation of salient events was associated with PTSD-SP
and correlated with the severity of psychotic symp-
toms. This points to symptom-specific functional
brain changes in patients with PTSD, which may be
relevant for future treatment studies.
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